|
|
Volumn 104, Issue 18, 2001, Pages
|
|
Report from the 94th Cardiovascular and Renal Drugs Advisory Committee Meeting, October 11, 2001.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOTENSIN 1 RECEPTOR;
ANGIOTENSIN RECEPTOR;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CARDIOVASCULAR AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DRUG DERIVATIVE;
SPIRONOLACTONE;
TETRAZOLE DERIVATIVE;
VALINE;
VALSARTAN;
ADVISORY COMMITTEE;
AGE;
CANADA;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONGESTIVE HEART FAILURE;
CONTROLLED CLINICAL TRIAL;
DRUG ANTAGONISM;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
GENETICS;
HUMAN;
HYPERKALEMIA;
KIDNEY FAILURE;
METHODOLOGY;
MORTALITY;
NEGRO;
RANDOMIZED CONTROLLED TRIAL;
STATISTICS;
SURVIVAL RATE;
UNITED STATES;
ADRENERGIC BETA-ANTAGONISTS;
ADVISORY COMMITTEES;
AFRICAN CONTINENTAL ANCESTRY GROUP;
AGE FACTORS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
CANADA;
CARDIOVASCULAR AGENTS;
DRUG APPROVAL;
HEART FAILURE, CONGESTIVE;
HUMANS;
HYPERKALEMIA;
KIDNEY FAILURE;
RANDOMIZED CONTROLLED TRIALS;
RECEPTOR, ANGIOTENSIN, TYPE 1;
RECEPTORS, ANGIOTENSIN;
SPIRONOLACTONE;
SURVIVAL RATE;
TETRAZOLES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
VALINE;
MLCS;
MLOWN;
|
|
EID: 0035976137
PISSN: None
EISSN: 15244539
Source Type: Journal
DOI: 10.1161/hc4301.101126 Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (0)
|
